| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S11894-008-0008-9 |
| P698 | PubMed publication ID | 18417042 |
| P50 | author | Lewis R. Roberts | Q38601327 |
| P2093 | author name string | Dalbir S Sandhu | |
| P2860 | cites work | Endoscopic application of photodynamic therapy for cholangiocarcinoma | Q30661106 |
| Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report | Q33357252 | ||
| Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer | Q33373474 | ||
| Risk factors for biliary tract carcinogenesis | Q33705452 | ||
| Biliary tract cancers. | Q33760399 | ||
| Role of US in the detection, characterization, and staging of cholangiocarcinoma | Q33874329 | ||
| Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings | Q33891055 | ||
| Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. | Q33961881 | ||
| Serum and bile markers for cholangiocarcinoma | Q33979059 | ||
| Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy | Q33984809 | ||
| Liver stem cells and their implication in hepatocellular and cholangiocarcinoma | Q33997118 | ||
| Outcomes after curative resections of cholangiocarcinoma | Q34061566 | ||
| Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma | Q34067350 | ||
| Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates | Q34322673 | ||
| AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity | Q34333732 | ||
| Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study | Q34543074 | ||
| Evaluation of the pancreaticobiliary ductal systems by intraductal US. | Q34545423 | ||
| Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis | Q34723706 | ||
| Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies | Q35007011 | ||
| Usefulness of 18 F-FDG PET in intrahepatic cholangiocarcinoma | Q35568070 | ||
| Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures | Q35585581 | ||
| The epidemiology of cholangiocarcinoma | Q35802314 | ||
| Resectable hilar cholangiocarcinoma: surgical treatment and long-term outcome | Q35938981 | ||
| Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients | Q35980414 | ||
| Photosensitizers and antioxidants: a way to new drugs? | Q36240215 | ||
| The effect of communication between the right and left liver on the outcome of surgical drainage for jaundice due to malignant obstruction at the hilus of the liver | Q36712470 | ||
| Current surgical treatment for bile duct cancer | Q36802509 | ||
| Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting. | Q39378674 | ||
| A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures | Q39678629 | ||
| Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib | Q40240678 | ||
| Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells | Q40715147 | ||
| Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging | Q40914178 | ||
| Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study | Q43589304 | ||
| Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer | Q43601169 | ||
| Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture | Q46600275 | ||
| A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer | Q46941755 | ||
| Cancer statistics, 1996. | Q50610104 | ||
| A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells. | Q51793104 | ||
| Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. | Q51989128 | ||
| Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. | Q52948765 | ||
| Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. | Q53414391 | ||
| Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. | Q53592052 | ||
| MR cholangiography versus cholangioscopy for evaluation of longitudinal extension of hilar cholangiocarcinoma. | Q53668588 | ||
| A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma. | Q54550602 | ||
| A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures | Q59150858 | ||
| Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis | Q70474940 | ||
| CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis | Q73417073 | ||
| Detection of telomerase reverse transcriptase mRNA in biopsy specimens and bile for diagnosis of biliary tract cancers | Q73442837 | ||
| Prospective study of biliary strictures to determine the predictors of malignancy | Q73889273 | ||
| MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension | Q74064052 | ||
| Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions | Q74096884 | ||
| Preoperative evaluation of Klatskin tumor: accuracy of spiral CT in determining vascular invasion as a sign of unresectability | Q74132628 | ||
| A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures | Q74148537 | ||
| Optical coherence tomography of the biliary tree during ERCP | Q77388592 | ||
| Value of brush cytology for dominant strictures in primary sclerosing cholangitis | Q77904284 | ||
| Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study | Q78559167 | ||
| Photodynamic therapy for cholangiocarcinoma | Q80191478 | ||
| Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas | Q80432017 | ||
| ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study | Q80497465 | ||
| Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma | Q81148310 | ||
| Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case | Q83821409 | ||
| P433 | issue | 1 | |
| P921 | main subject | diagnosis | Q16644043 |
| cholangiocarcinoma | Q124292 | ||
| P304 | page(s) | 43-52 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Current gastroenterology reports | Q26842032 |
| P1476 | title | Diagnosis and management of cholangiocarcinoma | |
| P478 | volume | 10 |
| Q37536184 | Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. |
| Q35507745 | Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma |
| Q37086246 | Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma |
| Q83557440 | Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma |
| Q39664471 | High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K |
| Q48351105 | Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma. |
| Q37598371 | Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells |
| Q30541284 | Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells |
| Q47101153 | Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells |
| Q37776432 | p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies |
Search more.